Linkage to Care for Persons With Hep C Infection (NCT05397067) | Clinical Trial Compass
CompletedNot Applicable
Linkage to Care for Persons With Hep C Infection
United States60 participantsStarted 2022-07-12
Plain-language summary
Hepatitis C Virus (HCV) infection is an ongoing challenge in the United States, with an estimated 2.4 million individuals living with HCV in 2016. According to the Virginia Department of Health, over 11,500 people were living with HCV infection in 2017 with a rate of 170 reported cases/100,000 adults. This study evaluated community-based interventions to improve linkage to care (LTC) among individuals with hepatitis C virus (HCV) infection and substance use disorders in Appalachia.
This study evaluated whether community-based interventions, including peer support, incentives, telehealth, and phone access, improve linkage to care among individuals with hepatitis C and substance use disorders in Appalachia.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* 18 years or older, positive Hepatitis C antibody test,
* elevated Hepatitis C RNA
* history of substance use disorder
Exclusion criteria:
* under 18 years old,
* history of treatment of Hepatitis C infection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on people with both Hepatitis C and substance use disorders — if I have one or both of these, is this the kind of combination of challenges my care team is equipped to help me navigate even outside of a trial like this?
2Since this trial is listed as completed, are there published results or findings from it that my doctor has seen, and do those results change how they'd approach linking me to Hepatitis C treatment?
3The trial seems to have focused on 'linkage to care' rather than testing a specific drug — what does that mean for my situation, and are there programs or pathways my doctor could connect me to that work in a similar way?
4If I also have a substance use disorder, how does that affect my options for Hepatitis C treatment, and are there coordinated programs locally that treat both conditions together the way this trial seemed to?
5Are there currently active trials or standard care protocols inspired by research like this one that might be a better fit for where I am right now in my diagnosis and treatment journey?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of Participants With Attendance at First Appointment
Timeframe: Through study completion, within 6 months of diagnosis